Starpharma Holdings Ltd (SPL.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -42 | -89 | -621 | -837 | -246 |
| Sale Of Investment | N/A | N/A | 11 | 1 | N/A |
| Investing Cash Flow | $-42 | $-89 | $-610 | $-836 | $-246 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 507 | 886 | N/A | 4,000 | N/A |
| Debt Repayment | -839 | -4,888 | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | N/A | N/A | 48,862 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -1,931 |
| Other Financing Activity | -796 | -745 | -695 | -772 | -628 |
| Financing Cash Flow | $-1,128 | $-4,747 | $-695 | $3,228 | $46,303 |
| Exchange Rate Effect | -24 | -7 | 100 | 188 | -803 |
| Beginning Cash Position | 23,360 | 35,180 | 49,918 | 60,500 | 30,054 |
| End Cash Position | 15,407 | 23,360 | 35,180 | 49,918 | 60,500 |
| Net Cash Flow | $-7,929 | $-11,813 | $-14,838 | $-10,770 | $31,249 |
| Free Cash Flow | |||||
| Capital Expenditure | -42 | -89 | -621 | -837 | -246 |
| Free Cash Flow | -42 | -89 | -621 | -837 | -246 |